
#D25TS_Picks
#TTEK: $40.65
Record Q3 net revenue of $1.11B (+8% YoY) and a surging $4.49B backlog highlight strong growth from global water infrastructure and environmental modernization spending.
Resistance: $42.5, $46 | Support: $39.3
For Detailed Analysis: https://t.me/c/2454754655/10750
#AMAT: $391
Q3 revenue up 25% YoY to $9.12B with >70% advanced packaging growth highlights market leadership across AI chip manufacturing and major fab expansions.
Resistance: $400, $413 | Support: $381.80
For Detailed Analysis: https://t.me/c/2454754655/10072
#SMMT: $17.83
Superior Phase 3 survival data over pembrolizumab and a $2B strategic investment from AstraZeneca highlight high-conviction growth ahead of key FDA decisions.
Resistance: $19.25, $21 | Support: $16.55
For Detailed Analysis: https://t.me/c/2454754655/10734
🚀 Join our ThinkSabio Stocks WL999 Group
To join, simply visit our ThinkSabio Community Page or access the ThinkSabio Bot.
🌐 https://www.thinksabio.com/community


Share this post
💬 Comments
Loading comments…
Leave a comment
